Showing results for "Stoke Therapeutics"
markets
European Stocks Decline as China Concerns Build; UK Stocks LagEuropean equities slipped amid light trading, as China’s central bank decision to unexpectedly cut a key interest rate failed to reassure markets about the country’s economic outlook, while UK blue-chips underperformed following record UK wage growth.August 15, 2023
business
What’s Happening in the World Economy: Easing Restrictions Offer Upside SurpriseHello. Today we look at the potential impact on growth and inflation from easing Covid-19 restrictions, the damage to Latin America’s biggest economy from interest-rate hikes, and quantifying the growth drag from fading fiscal stimulus.February 10, 2022
politics
Trudeau Begins Third Term With Stronger Finances Than ExpectedPrime Minister Justin Trudeau’s government released new budget estimates that showed an improving economy and smaller deficits than projected, though tens of billions of dollars in campaign pledges have yet to be accounted for.December 14, 2021
business
Sydney to End Quarantine, Moderna Gets Booster Nod: Virus UpdateAustralia’s most populous state will open its borders to fully vaccinated travelers -- who will no longer need to quarantine -- from Nov. 1. The policy shift will end more than 18 months of near-isolation from the rest of the world.October 14, 2021
markets
Chinese Firm Buys Canada mRNA Vaccine Tech in $500 Million DealChinese biopharma firm Everest Medicines Ltd. will license an mRNA Covid-19 vaccine from Canada’s Providence Therapeutics Holdings Inc., as companies try to bring the most effective inoculation platform into China despite its apparent resistance to western shots.September 13, 2021
